ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,707Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 1300

$363K Total Retail Price of All Prescriptions

Rank: 89 out of 1300

320 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 320 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

23% of this provider’s 320 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 7,988 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
AMLODIPINE BESYLATE 660 591 1 6
LISINOPRIL 554 488 2 2
OMEPRAZOLE 488 411 3 4
LEVOTHYROXINE SODIUM 430 376 4 1
METFORMIN HCL 365 271 5 7
SIMVASTATIN 364 308 6 3
HYDROCODONE-ACETAMINOPHEN 354 248 S3 7 5
HYDROCHLOROTHIAZIDE 248 217 8 10
FUROSEMIDE 225 199 9 8
ALENDRONATE SODIUM 204 194 10 20
WARFARIN SODIUM 182 178 11 9
METOPROLOL SUCCINATE 182 159 11 24
POTASSIUM CHLORIDE 153 119 13 18
METOPROLOL TARTRATE 123 105 14 11
TRAMADOL HCL 120 76 15 17
RANITIDINE HCL 119 67 16 27
PAROXETINE HCL 117 114 17 59
KLOR-CON M20 114 106 18 60
ATORVASTATIN CALCIUM 112 96 19 13
DIOVAN 98 87 20 66
FLUTICASONE PROPIONATE 81 53 21 30
ZOLPIDEM TARTRATE 75 51 22 14
GLIPIZIDE XL 74 64 23 142
GLIPIZIDE ER 73 66 24 99
LOVASTATIN 70 49 25 22
TAMSULOSIN HCL 70 55 25 25
ENDOCET 66 24 S2 27 164
AMITRIPTYLINE HCL 64 64 R 28 63
SERTRALINE HCL 63 47 29 26
PRAVASTATIN SODIUM 63 63 29 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 36 31 21
PREDNISONE 61 42 32 40
ISOSORBIDE MONONITRATE ER 60 60 33 82
AMLODIPINE BESYLATE-BENAZEPRIL 60 59 33 149
SPIRONOLACTONE 58 58 35 55
CIPROFLOXACIN HCL 57 53 36 87
ATENOLOL 56 56 37 12
LANTUS 53 26 38 43
IBUPROFEN 50 24 39 72
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 37 39 128
CITALOPRAM HBR 50 32 39 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.